Research Information Only — Educational content, not medical advice. Longevity compounds are largely research/investigational. Epithalon is contraindicated in cancer. Physician review required.
Why This Hub Exists
The one place a stack is actually justified
In most categories, stacking is overkill. Longevity is the exception — because aging attacks on multiple fronts at once, and no single compound covers them all. Telomere maintenance, NAD+ restoration, mitochondrial protection, and immune resilience are distinct problems needing distinct tools. The skill isn't picking one; it's assembling the right combination, staged and screened, without wandering into the compound that a cancer history forbids.
The core ideaMap compound to hallmark: Epithalon → telomeres, NAD+ → cellular energy/DNA repair, SS-31 → mitochondria, with metabolic, hormonal, tissue, and immune supports layered on. A longevity protocol is a coordinated stack, not a single shot.
The Landscape
The compounds, by hallmark
Also relevant: GHK-Cu (gene-expression and tissue longevity) and Humanin (mitochondrial-derived longevity signal) — see their profiles.
The Differentiator
Which hallmark, which compound
Longevity Selection Logic
The aging dimension in focus routes to what gets used.
If longevity is the primary focus
→
Epithalon + NAD+ + SS-31 (+ MOTS-c) — the full stack.
If 45+ with anti-aging interest (minimum)
→
Epithalon + NAD+ — the core two.
If active lifestyle / hormonal aging
→
Add CJC-1295 + ipamorelin.
If immune decline is noted
→
Add Thymosin Alpha-1.
Locked rules: Epithalon runs 10 consecutive days, repeated ~quarterly (never continuous) · NAD+ and SS-31 each dose in their own separate syringe.
The screen that gates the categoryEpithalon activates telomerase — the same enzyme cancer cells exploit to become immortal. It is contraindicated in active cancer and should be avoided with a cancer history. Any longevity protocol in someone with a cancer history belongs with an oncologist, not a general guide.
Mechanism, Plainly
Four fronts of aging
01
Telomeres — the cellular clock
Telomeres cap chromosomes and shorten with each cell division. Epithalon supports telomere maintenance via the pineal/telomerase axis — targeting one recognized hallmark of aging.
02
NAD+ — the energy currency
NAD+ powers energy metabolism, DNA repair, and sirtuin signaling, and it falls with age. Restoring it is among the most-studied longevity levers.
03
Mitochondria — the power plants
SS-31 stabilizes cardiolipin, protecting the mitochondrial membrane where energy is made — structural resilience at the cellular level.
04
Immune drift — immunosenescence
The aging immune system becomes both weaker and more inflammatory. Thymosin Alpha-1 addresses this immune dimension of aging when it's part of the picture.
Evidence Snapshot
What the research shows — and doesn't
| Compound | Hallmark | Status & evidence |
|---|
| Epithalon | Telomere | Research compound; Russian research lineage. Contraindicated in active cancer. |
| NAD+ | Cellular energy | Widely used; strong mechanistic basis, human longevity-outcome data still limited. |
| SS-31 (elamipretide) | Mitochondria | In clinical development for inherited mitochondrial disease; longevity use is extrapolation. |
| MOTS-c | Metabolic | Research compound; preclinical/mechanistic metabolic-longevity support. |
Honest framingThese compounds target real, recognized hallmarks of aging, and animal data supports healthspan roles. But controlled human lifespan trials do not exist. Treat longevity peptides as scientifically serious, still-investigational tools — not proven life-extension.
Safety Screen
What gets checked first
- Epithalon + cancer. Telomerase activation — contraindicated in active cancer; avoid with cancer history.
- GH-axis + cancer. IGF-1 elevation cautioned with cancer history (see the cancer-history safety guide).
- Pulsed dosing. Epithalon is a 10-day course repeated quarterly — not continuous; this is a locked rule.
- Separate syringes. NAD+ and SS-31 each dose alone.
- Realistic expectations. Longevity effects are slow and hard to feel; this is a long-horizon, biomarker-guided strategy, not a compound you judge by next week.
- Source quality. Certificate of analysis essential.
Common Questions
Longevity peptide questions answered
What's the core longevity stack?
Epithalon (telomeres), NAD+ (cellular energy/DNA repair), and SS-31 (mitochondria), often with MOTS-c for the metabolic dimension. Each targets a different hallmark of aging, which is why longevity is one of the few categories where a stack is genuinely justified.
Is Epithalon safe if I've had cancer?
No — it activates telomerase, which cancer cells exploit. It's contraindicated in active cancer and should be avoided with a cancer history. This is the defining screen of the longevity category, and it's an oncology decision, not a self-directed one.
How is Epithalon taken?
In pulsed courses — about 10 consecutive days, repeated roughly quarterly — not continuously. That cyclical pattern is one of the locked rules here.
Will these make me live longer?
In humans, the honest answer is unproven. They target recognized aging hallmarks and animal data supports healthspan, but no controlled human lifespan trial exists. They're serious longevity candidates, judged over a long horizon with biomarkers — not proven life-extension.
Not Sure Where You Fit?
Take the 60-second quizAnswer a few questions and get honest, clinician-built education matched to your goal — then a personalized report. No hype, no prescription.
Which peptide is right for you? →
About the Author
SD
Dr. Scott DelBoccio, DMD
Founding Author · PeptideReport.ai
Dr. DelBoccio is a clinician with thirty years of practice and a focus on peptide pharmacology and longevity medicine. PeptideReport.ai is the clinician-authored, education-only reference the peptide space lacked — every hub reflects an independent synthesis of the primary literature and the same selection logic that drives the platform's personalized reports. No products are sold on this site.
Full Disclaimer
This hub is for educational and scientific purposes only and does not constitute medical advice, diagnosis, or treatment. The compounds discussed are research/investigational; longevity associations are mechanistic and observational and do not establish extended human lifespan. Epithalon is contraindicated in active cancer and GH-axis compounds are cautioned with a cancer history. Any longevity protocol should be built and supervised by a qualified physician, with oncology involvement where a cancer history exists. PeptideReport.ai does not manufacture, sell, or endorse any preparation. Content addresses adults 21 and older. Evidence and regulatory status continue to evolve.